Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page
- Check5 days agoChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page metadata.SummaryDifference0.0%

- Check48 days agoChange Detected- Revision: v3.4.3 was added. - Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded Revision: v3.4.2; the previous notices including Revision: v3.4.1 about government funding lapse and NIH Clinical Center operating status were removed.SummaryDifference0.4%

- Check84 days agoChange DetectedThe page now displays a government funding lapse notice with open-status guidance and a new release version labeled v3.4.1, replacing the previous v3.4.0. These updates are site-wide notices rather than alterations to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.